In vivo evaluation of an innovative synbiotics on stage IIIb-IV chronic kidney disease patients

Overview of attention for article published in Frontiers in Nutrition, June 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 56,283 followers.

RT @HealthyFellow: In vivo evaluation of an innovative #synbiotic on stage IIIb-IV chronic #kidney disease https://t.co/2jc3K2L1ka @_atanas…

RT @HealthyFellow: In vivo evaluation of an innovative #synbiotic on stage IIIb-IV chronic #kidney disease https://t.co/2jc3K2L1ka @_atanas…

RT @HealthyFellow: In vivo evaluation of an innovative #synbiotic on stage IIIb-IV chronic #kidney disease https://t.co/2jc3K2L1ka @_atanas…

RT @HealthyFellow: In vivo evaluation of an innovative #synbiotic on stage IIIb-IV chronic #kidney disease https://t.co/2jc3K2L1ka @_atanas…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.